Renal Cell Carcinoma
Clinical Management
(Sprache: Englisch)
This valuable clinical resource profiles the new staging system for renal cell carcinoma, reviews fresh data on risk factors, and details new perspectives on renal tumor imaging. It also includes the latest on the molecular biology of metastatic kidney cancer.
Jetzt vorbestellen
versandkostenfrei
Buch (Gebunden)
164.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Renal Cell Carcinoma “
This valuable clinical resource profiles the new staging system for renal cell carcinoma, reviews fresh data on risk factors, and details new perspectives on renal tumor imaging. It also includes the latest on the molecular biology of metastatic kidney cancer.
Klappentext zu „Renal Cell Carcinoma “
Renal Cell Carcinoma: Clinical Management provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in kidney cancer. The volume reviews new data about risk factors for the disease, profiles the new staging system for renal cell carcinoma (RCC), highlights our current understanding of familial syndromes of RCC and their molecular genetics, and provides new perspectives about imaging of renal tumors. For localized disease, a greater appreciation of nephron-sparing approaches and the importance of preservation of renal function is discussed in detail. Advances in surgical techniques are highlighted. For metastatic disease, the molecular biology of kidney cancer is reviewed in a concise and understandable manner, including the data that has fostered novel targeted approaches that have revolutionized management. The several landmark phase III targeted therapy trials published in the last few years are placed in context with respect to current management. Integration of surgery and systemic therapy through cytoreductive and consolidative approaches has yielded provocative data that promises to further advance the field, and major advances in this domain are also be discussed.
Inhaltsverzeichnis zu „Renal Cell Carcinoma “
Section I: Localized Disease1. Etiology of RCC: Incidence, Demographics, and Environmental Factors
By Frédéric D. Birkhäuser, MD, Nils Kroeger, MD, and Allan J. Pantuck, MD MS FACS
2. Pathology of Renal Cell Carcinoma
By Ming Zhou, MD PhD, Huiying He
3. Familial Renal Cell Carinoma
By Simon P. Kim, MD, MPH, Bradley C. Leibovich, MD
4. Imaging of Renal Cell Carcinoma
By Andrei S. Purysko, MD, Erick M. Remer MD, Brian R. Herts, MD
5. Prognostic Factors for Localized Renal Cell Carcinoma
By Brian R. Lane, MD, PhD.
Section II: Management of Localized RCC
6. Assessment of Oncologic Risk for Clinical Stage T1 Renal Tumors and the Emerging Role of Renal Mass BiopsyBy Matthew N. Simmons MD PhD, Steven C. Campbell MD PhD
7. Radical Nephrectomy for Localized Renal Tumors: Oncological and Renal Functional Considerations
By Paul Russo, MD FACS
8. Nephron-Sparing Surgery for Renal Cancer
By Alon Z. Weizer MD, MS, Jeffery S. Montgomery MD, MHSA, Khaled S. Hafez, MD
9. Thermal Ablation
By Surena F. Matin MD FACS, Kamran Ahrar MD
10. Active Surveillance of the Small Renal Mass
By Marc C. Smaldone, MD, Daniel Canter, MD, Alexander Kutikov, MD, Robert G. Uzzo, MD FACS
Section III: Locally Advanced Disease
11. Locally Advanced Renal Cell Carcinoma
By Stephen H. Culp, MD PhD, Christopher G. Wood, MD FACS
12. Neoadjuvant Targeted Therapy and Consolidative Surgery
By Sean P. Stroup MD. Ithaar H. Derweesh, MD
Section IV: Advanced Disease
13. Biology of RCC (VEGF, mTOR, immune aspects)
By Alexandra Arreola, W. Kimryn Rathmell, MD, PhD
14. Prognostic Factors in Advanced Renal Cell Carcinoma
By
... mehr
Michael M. Vickers MD, Daniel Y. C. Heng MD MPH
15. Integration of Surgery in Metastatic Renal Cancer
By Tom Powles, MBBS MRCP MD, Axel Bex, MD
16. Immunotherapy for Renal Cell Carcinoma
By Diwakar Davar, MD, Moon Fenton, MD, Leonard J Appleman, MD, PhD
17. Targeted Therapy: Vascular Endothelial Growth Factor (VEGF)
By Linda Cerbone MD, Cora N. Sternberg, MD
18. mTOR in Renal cell carcinoma
By Eric Jonasch, MD, Michel Choueiri, MD
19. Palliative and Supportive Care for Renal Cancer
By Armida Parala-Metz MD, Mellar Davis MD
15. Integration of Surgery in Metastatic Renal Cancer
By Tom Powles, MBBS MRCP MD, Axel Bex, MD
16. Immunotherapy for Renal Cell Carcinoma
By Diwakar Davar, MD, Moon Fenton, MD, Leonard J Appleman, MD, PhD
17. Targeted Therapy: Vascular Endothelial Growth Factor (VEGF)
By Linda Cerbone MD, Cora N. Sternberg, MD
18. mTOR in Renal cell carcinoma
By Eric Jonasch, MD, Michel Choueiri, MD
19. Palliative and Supportive Care for Renal Cancer
By Armida Parala-Metz MD, Mellar Davis MD
... weniger
Bibliographische Angaben
- 2012, XI, 362 Seiten, Maße: 18,3 x 26 cm, Gebunden, Englisch
- Herausgegeben: Steven C. Campbell, Brian I. Rini
- Verlag: Springer, Berlin
- ISBN-10: 1627030611
- ISBN-13: 9781627030618
Sprache:
Englisch
Rezension zu „Renal Cell Carcinoma “
From the reviews:"Editors S. Campbell and B. Rini, with the support of 40 experts, aimed to come out with an update on recent innovations, focusing on clinical implications. ... A very well-illustrated chapter dealt with various pathological aspects of RCC, including molecular genetics, while another chapter focused on family diseases. ... This textbook offers practical information which is of special interest to all urologists and oncologists involved in RCC management." (European Urology Today, Vol. 25 (3), June-July, 2013)
Pressezitat
From the book reviews:"Editors S. Campbell and B. Rini, with the support of 40 experts, aimed to come out with an update on recent innovations, focusing on clinical implications. ... A very well-illustrated chapter dealt with various pathological aspects of RCC, including molecular genetics, while another chapter focused on family diseases. ... This textbook offers practical information which is of special interest to all urologists and oncologists involved in RCC management." (European Urology Today, Vol. 25 (3), June-July, 2013)
"This is a concise but comprehensive review of renal cell carcinoma from etiology and risk factors to medical and surgical management. ... This is an excellent resource for any practitioner with an interest in renal cell carcinoma. ... this book would appeal to general oncologists, urologists, general surgeons, radiologists, pathologists, nephrologists, internists, family practitioners, fellows, residents, and students. ... It is thorough, clearly written, and logically presented." (Jean Hoffman-Censits, Doody's Book Reviews, February, 2013)
Kommentar zu "Renal Cell Carcinoma"
Schreiben Sie einen Kommentar zu "Renal Cell Carcinoma".
Kommentar verfassen